BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9261335)

  • 41. Hypothermia augments polymorphonuclear leukocyte degranulation and interleukin-8 production from human umbilical vein endothelial cells and increases lipopolysaccharide-induced polymorphonuclear leukocyte-endothelial cell interaction when followed by normothermia.
    Sakao Y; Nakahara Y; Carr FK; Miller EJ
    J Cardiothorac Vasc Anesth; 2002 Oct; 16(5):561-6. PubMed ID: 12407606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-4 and interleukin-10 increase endotoxin-stimulated human umbilical vein endothelial cell interleukin-8 release.
    De Beaux AC; Maingay JP; Ross JA; Fearon KC; Carter DC
    J Interferon Cytokine Res; 1995 May; 15(5):441-5. PubMed ID: 7648446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biochemical and microscopic evidence for the internalization and degradation of heparin-containing mast cell granules by bovine endothelial cells.
    Atkins FM; Friedman MM; Metcalfe DD
    Lab Invest; 1985 Mar; 52(3):278-86. PubMed ID: 3974200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin.
    Roth RI
    Blood; 1994 May; 83(10):2860-5. PubMed ID: 8180381
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human mast cells (HMC-1 5C6) enhance interleukin-6 production by quiescent and lipopolysaccharide-stimulated human coronary artery endothelial cells.
    Walia DS; Sharma M; Raveendran VV; Zhou J; Sharma R; Stechschulte DJ; Dileepan KN
    Mediators Inflamm; 2012; 2012():274347. PubMed ID: 22363102
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phagocytosis of mast cell granules by cultured fibroblasts.
    Subba Rao PV; Friedman MM; Atkins FM; Metcalfe DD
    J Immunol; 1983 Jan; 130(1):341-9. PubMed ID: 6847886
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Morphological changes in rat aortic endothelial cell line stimulated by endothelin.
    Xin X; Cai Y; Chikamori-Aoyama M; Mori N; Kishino Y; Agui T
    Tokushima J Exp Med; 1994 Dec; 41(3-4):79-86. PubMed ID: 7701508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-6 and IL-8 production from cultured human endothelial cells stimulated by infection with Rickettsia conorii via a cell-associated IL-1 alpha-dependent pathway.
    Kaplanski G; Teysseire N; Farnarier C; Kaplanski S; Lissitzky JC; Durand JM; Soubeyrand J; Dinarello CA; Bongrand P
    J Clin Invest; 1995 Dec; 96(6):2839-44. PubMed ID: 8675654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial cell activation by mast cell mediators.
    Dileepan KN; Stechschulte DJ
    Methods Mol Biol; 2006; 315():275-94. PubMed ID: 16110164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages.
    Feder LS; Todaro JA; Laskin DL
    J Leukoc Biol; 1993 Feb; 53(2):126-32. PubMed ID: 8445325
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Actions of endotoxin and morphine.
    Chang SL; Felix B; Jiang Y; Fiala M
    Adv Exp Med Biol; 2001; 493():187-96. PubMed ID: 11727765
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of tissue factor and cytokine release.
    Gray E; Thomas S; Mistry Y; Poole S
    Haemostasis; 1996; 26 Suppl 1():92-5. PubMed ID: 8904180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of eosinophil peroxidase to mast cell granules with retention of peroxidatic activity.
    Henderson WR; Jong EC; Klebanoff SJ
    J Immunol; 1980 Mar; 124(3):1383-8. PubMed ID: 6987310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological profile of KE-758, the main metabolite of the antirheumatic agent KE-298.
    Yasuda Y; Inoue T; Takeshita K
    Drugs Exp Clin Res; 1996; 22(1):1-8. PubMed ID: 8839631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation.
    May LT; Torcia G; Cozzolino F; Ray A; Tatter SB; Santhanam U; Sehgal PB; Stern D
    Biochem Biophys Res Commun; 1989 Mar; 159(3):991-8. PubMed ID: 2649105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Catecholamines up-regulate lipopolysaccharide-induced IL-6 production in human microvascular endothelial cells.
    Gornikiewicz A; Sautner T; Brostjan C; Schmierer B; Függer R; Roth E; Mühlbacher F; Bergmann M
    FASEB J; 2000 Jun; 14(9):1093-100. PubMed ID: 10834930
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood.
    Souter PJ; Thomas S; Hubbard AR; Poole S; Römisch J; Gray E
    Crit Care Med; 2001 Jan; 29(1):134-9. PubMed ID: 11176173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Human corneal epithelial, stromal and endothelial cells produce interleukin-6].
    Sakamoto S; Inada K
    Nippon Ganka Gakkai Zasshi; 1992 Jun; 96(6):702-9. PubMed ID: 1626470
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inducer-specific bidirectional regulation of endothelial interleukin-8 production by thalidomide.
    Dunzendorfer S; Herold M; Wiedermann CJ
    Immunopharmacology; 1999 Jun; 43(1):59-64. PubMed ID: 10437657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The biologic activity of mast cell granules. VI. The effect of vinblastine-induced neutropenia on rat cutaneous late phase reactions.
    Lemanske RF; Guthman DA; Oertel H; Barr L; Kaliner M
    J Immunol; 1983 Jun; 130(6):2837-42. PubMed ID: 6854018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.